Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Heparin Sodium

High Purity Supply Heparin Sodium with low price CAS: 9041-08-1

 

  • Lebitso la sehlahisoa:

    Heparin Sodium

  • Kereiti:

    Pharmaceutical grade

  • Thepa:

    phofo e tšoeu

  • Ho paka:

    25kg/bag/drum

  • MOQ:

    1 ton

  • Polokelo:Cool Dry Place
  • Shelf bophelo:lilemo tse 2


Lintlha

Li-tag

Tlhaloso ea Sehlahisoa

 

Heparin sodium, an anticoagulant, is a mucopolysaccharide. It is a sodium salt of glucosamine sulfate extracted from the intestinal mucosa of pigs, cattle and sheep. It is secreted by mast cell in the human body and naturally exists in the blood. Heparin sodium has the function of preventing platelet aggregation and destruction, inhibiting the transformation of fibrinogen into fibrin monomers, inhibiting the formation of thromboplastin and antagonizing the formed thromboplastin, preventing the transformation of prothrombin into thrombin, and antagonizing thrombin.

 

Pontšo ea Sehlahisoa

 

 

Likaroloana

 

1. Biochemical studies; used for preventing the conversion of prothrombin into thrombin; has blood anti-thrombosis effect.
2. For the delay and prevention of blood clotting.
3.
Heparin sodium salt is a mucopolysaccharides biochemical medicine extracted from porcine small intestinal mucosa with strong anticoagulant activity. Mclcan found it from the liver tissue of dog in the study of the clotting mechanism. Brinkous et al proved that heparin having anticoagulant activity. After the first application of heparin as an anticoagulant in clinical filed, it has drawn worldwide attention. With a strong anticoagulant effect, heparin is the primary choice for prevention and treatment of deep vein thrombosis and other thrombotic diseases.

 

Kopo

 

1. The treatment of various diseases concurrent disseminated intravascular coagulation early.
2. Prevention of arterial and venous thrombosis and pulmonary embolism.
3. Treatment of arterial and venous thrombosis and pulmonary embolism, ischemic stroke, unstable angina
(to alleviate the symptoms, prevention of myocardial infarction), acute myocardial infarction (prevention of
early reinfarction and infarct extension, reduce mortality).
4. The artificial lung, peritoneal dialysis or hemodialysis as anticoagulants.
5. thrombolytic therapy as maintenance therapy.
6. Heparin lithium used for the prevention of blood coagulation and blood bank transfusion of blood and
other body save my save.

 

Melemo

 

Re na le lifeme tse ngata tsa boleng bo holimo tse nang le tšebelisano e tebileng, tse ka u fang lihlahisoa tsa boleng bo holimo le litheko tsa tlholisano. Hape re ka fana ka litheolelo bakeng sa ho reka ka bongata.'Me re sebelisana le lik'hamphani tse ngata tsa litsebi tse tsamaisang thepa, li ka isa lihlahisoa ka mokhoa o sireletsehileng le ka thelelo matsohong a hau. Nako ea ho fana e ka ba matsatsi a 3-20 ka mor'a hore ho netefatsoe tefo.

Tlhaloso

 

检验项目 Ntho

Litekanyetso

检验结果  test result

Ponahalo

White or almost white hygroscopic powder

E lumellana

Solubility

Freely soluble in water

E lumellana

 

Identification A

It delays the clothing of   recalcified citrated sheep plasma.

 

E lumellana

Identification B

1H-NMR

E lumellana

 

 

 

 

Identification C

 

In the chromatogram of related substance, the principal peak    obtained with test solution is     similar in retention time and

shape to the principal peak in the chromatogram obtained    with reference solution.

 

 

 

 

E lumellana

Identification D

It complies with the test for sodium

E lumellana

 

 

Appearance of solution

A: The solution is clear.

E lumellana

B: The solution is not more intensely coloured than

reference solution Y5.

 

E lumellana

PH

5.5~8.0

7.3

Nucleotidic impurities

Absorbance at 260 nm: ≤0.15

0.041

Protein

≤0.5%(Dried substance)

0.06%

 

 

 

 

 

 

Related substances

 

Dermatan Sulfate+Chondroitin  Sulfate: not more than the area of the peak due to dermatan

sulfate and chondroitin sulfate in the chromatogram obtained

with reference solution (e)(2.0%)

 

 

 

 

<0.1%

Any other impurity:

No peaks other than the peak due to dermatan

sulfate+chondroitin sulfate are detected

 

 

E mpe

Nitrogen

1.5%~2.5%(Dried substance)

2.10%

Sodium

10.5%~13.5%(Dried substance)

11.90%

Litšepe tse boima

≤30ppm

E lumellana

Loss on drying

≤8.0%

1.00%

Becterial endotoxins

<0.01 IU/IU

E lumellana

Protency

 

156 IU/mg

Potency(dried substance)

≥150 IU/mg(Dried substance)

158 IU/mg

Specific rotation

≥+50°

:+55°

 

Molecular weight determinations

Mw: 15,000~ 19,000Da;

M24000~≤20%;              ~

≥1.0

15100

11%

2.3

Residual solvents

Ethanol≤4500ppm

1298ppm

 

 

 

 

 

Microbial contamination

A: TAMC≤10 CFU/g TYMC≤10 CFU/g

B: Specified micro organisms Escherichia coli:

negative

Salmonella:               negative Pseudomonas aeruginosa:

negative

 

 

<10 CFU/g <10 CFU/g

Negative Negative negative

Detection conclusion

Comply with the EP & In-house specification.

 

Tsebo ea sehlahisoa:

 

Heparin sodium salt, used as an anticoagulant, is a mucopolysaccharide substance, is the sodium salt form of glucosamine sulfate extracted from the intestinal mucosa of pigs, cattle, and sheep. It is secreted by mast cells to be naturally presented the blood inside the human bodies. Heparin can prevent platelet aggregation and destruction, inhibit the conversion from fibrinogen to fibrin monomers, inhibit the formation of thromboplastin and fight against the pre-formed thromboplastin, and also prevent the conversion of prothrombin to thrombin and counteract the antithrombin.

Heparin sodium can delay or prevent blood clotting both in vivo and in vitro. Its mechanism of action is extremely complex and has an impact on many aspects of the coagulation process. Its function is:

1,to inhibit the formation and action of coagulation activating enzymes, thereby preventing the transformation of prothrombin into thrombin;
2,At high concentrations, it has the effect of inhibiting thrombin and other coagulation factors, hindering the transformation of fibrinogen into fibrin;
3,It can prevent the aggregation and destruction of platelet chemobooks. In addition, the anticoagulant effect of heparin sodium is still related to the negatively charged sulfate ions in its molecules. Positive charged alkaline substances such as protamine or toluidine blue can neutralize its negative charge, thus inhibiting its anticoagulant effect. Due to the activation and release of lipoprotein esterase by heparin in the body, it hydrolyzes the triglycerides and low-density lipoprotein of chyle particles, resulting in a lipid-lowering effect.

 

Ho romella le ho lefa

 

 

LBH

 

1. Na u feme kapa k'hamphani ea khoebo?
Re komnay e kopanyang indasteri le khoebo, ho fana ka ts'ebeletso e le 'ngoe.OEM e ka amoheloa.

2. O fana ka mehlala? Na ke mahala kapa ho feta?
Mehlala ea mahala. Tefiso ea thepa ea sampole e hloka ho lefuoa ka lehlakore la hau.

3. O na le litifikeiti tse amanang le taolo ea boleng?
Setifikeiti sa ISO 9001:2008 ho netefatsa boleng.

4. Ke fane ka eng ho fumana khotheishene?
Pls re tsebise ka mofuta oa sehlahisoa seo u se hlokang, bongata ba odara, aterese le litlhoko tse ikhethileng. Khotheishene e tla etsoa bakeng sa referense ea hau ka nako.

5. U khetha mofuta ofe oa mokhoa oa ho lefa? Ke mantsoe a mofuta ofe a amoheloang?
Melao e Amoheletsoeng ea Thomello: FOB,CFR,CIF,EXW;
Chelete ea Tefo e Amoheletsoeng: USD;
Mofuta oa Tefo o Amoheletsoeng: T/T, Western Union; Paypal, Tiisetso ea Khoebo.
Puo e Builoeng: Senyesemane.

 

Haeba u thahasella lihlahisoa tsa rona, u ka khetha ho siea lintlha tsa hau mona, 'me re tla buisana le uena haufinyane.


Ngola molaetsa wa hao mona mme o re romele wona